Major Depressive Disorder - ESKETINSUI2002 (Janssen)

Clinical trial to examine the efficacy and safety of an investigational medication - esketamine (given as a nasal spray) - in adolescents hospitalized with depression and suicidal ideation.

Qualified participants include:

  • Adolescents aged 12 to 17 years old
  • Have a diagnosis of major depressive disorder and are currently experiencing suicidal ideation
  • Currently prescribed or willing to switch to a study-approved antidepressant

Those that qualify will: 

  • Receive study-related care with a board-certified child and adolescent psychiatrist and other clinical staff at no cost
  • Receive reimbursement for study-related travel costs

Contact Clinical Trials at 860.545.7476 or via email

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, please email
 or call 860.545.7476.

Click here to join